My research is centered around developing and applying affinity proteomics technologies for analysis of human body fluids, mainly cerebrospinal fluid and plasma. The main focus is on neurodegenerative disorders and the aim to find proteins with potential for patient stratification in clinical applications.
Anna Månberg
Key Publications
Biological signatures in the Alzheimer’s continuum discriminate between diagnosis-related and -unrelated associations to ATN categories
Brain Communications, 2025
Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2025
Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis
2024
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
Journal of Internal Medicine, 2022
Autoantibody profiles associated with clinical features in psychotic disorders
Translational Psychiatry, 2021